XML 41 R22.htm IDEA: XBRL DOCUMENT
v3.20.1

Capital Stock Repurchase Plan Transactions | 3 Months Ended
--- | ---
Mar. 31, 2020
Capital Stock Repurchase Plan Transactions [Abstract] |
Capital Stock Repurchase Plan Transactions | 15. Capital Stock Repurchase Plan Transactions We repurchased the following capital stock:
|  | Three months ended March 31,
|  | 2020 |  | 2019
Total cost of repurchased shares (in thousands) |  | $ | 100,235 |  | $ | 49,250
Shares repurchased |  |  | 225,000 |  |  | 150,000
Weighted average price per share |  | $ | 445.49 |  | $ | 328.33
In March 2020, the Board of Directors authorized an additional $250.0 million for stock repurchase under Chemed’s existing share repurchase program. We currently have $253.8 million of authorization remaining under this share repurchase plan.

X
- References No definition available. + Details
Name: | us-gaap_PaymentsForRepurchaseOfEquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration